Literature DB >> 17448864

Intensity-modulated radiotherapy for early larynx cancer: is there a role?

Steven J Feigenberg, Miriam Lango, Nicos Nicolaou, John A Ridge.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17448864     DOI： 10.1016/j.ijrobp.2007.01.006

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  12 in total

1.  Outcomes of carotid-sparing IMRT for T1 glottic cancer: Comparison with conventional radiation.

Authors:  Abdallah S R Mohamed; Blaine D Smith; Joshua B Smith; Parag Sevak; Jessica S Malek; Aasheesh Kanwar; Theodora Browne; G Brandon Gunn; Adam S Garden; Steven J Frank; William H Morrison; Jack Phan; Mark Zafereo; Heath Skinner; Stephen Y Lai; Katherine A Hutcheson; Jan S Lewin; Amy E Hessel; Apurva A Thekdi; Randal S Weber; Clifton D Fuller; David I Rosenthal
Journal:  Laryngoscope       Date:  2019-02-12       Impact factor: 3.325

2.  An investigation of intensity-modulated radiation therapy versus conventional two-dimensional and 3D-conformal radiation therapy for early stage larynx cancer.

Authors:  Daniel Gomez; Oren Cahlon; James Mechalakos; Nancy Lee
Journal:  Radiat Oncol       Date:  2010-08-26       Impact factor: 3.481

3.  Carotid sparing intensity-modulated radiation therapy achieves comparable locoregional control to conventional radiotherapy in T1-2N0 laryngeal carcinoma.

Authors:  Zachary S Zumsteg; Nadeem Riaz; Sana Jaffery; Man Hu; Daphna Gelblum; Ying Zhou; Borys Mychalczak; Michael J Zelefsky; Suzanne Wolden; Shyam Rao; Nancy Y Lee
Journal:  Oral Oncol       Date:  2015-05-07       Impact factor: 5.337

4.  Risk of fatal cerebrovascular accidents after external beam radiation therapy for early-stage glottic laryngeal cancer.

Authors:  Samuel Swisher-McClure; Nandita Mitra; Alexander Lin; Peter Ahn; Fei Wan; Bert O'Malley; Gregory S Weinstein; Justin E Bekelman
Journal:  Head Neck       Date:  2013-07-02       Impact factor: 3.147

5.  Volumetric modulated arc radiotherapy of the whole larynx, followed by a single affected vocal cord, for T1a glottic cancer: Dosimetric analysis of a case.

Authors:  Seung-Gu Yeo
Journal:  Mol Clin Oncol       Date:  2016-01-14

6.  Outcomes after radiation therapy for T2N0/stage II glottic squamous cell carcinoma.

Authors:  Karine A Al Feghali; Bassem Y Youssef; Abdallah S R Mohamed; Lara Hilal; Blaine D Smith; Ibrahim Abu-Gheida; Georges Farha; G Brandon Gunn; Jack Phan; Jan Lewin; Apurva Thekdi; William H Morrison; Adam S Garden; Clifton David Fuller; David I Rosenthal
Journal:  Head Neck       Date:  2020-06-02       Impact factor: 3.147

7.  Simple carotid-sparing intensity-modulated radiotherapy technique and preliminary experience for T1-2 glottic cancer.

Authors:  David I Rosenthal; Clifton D Fuller; Jerry L Barker; Bryan Mason; John A Garcia; Jan S Lewin; F Christopher Holsinger; C Richard Stasney; Steven J Frank; David L Schwartz; William H Morrison; Adam S Garden; K Kian Ang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-08-11       Impact factor: 7.038

Review 8.  Standardisation of Target Volume Delineation for Carotid-sparing Intensity-modulated Radiotherapy in Early Glottis Cancer.

Authors:  D M Gujral; M Long; J W G Roe; K J Harrington; C M Nutting
Journal:  Clin Oncol (R Coll Radiol)       Date:  2016-11-01       Impact factor: 4.126

9.  Definitive radiotherapy for early stage glottic cancer by 6 MV photons.

Authors:  Chi-Chung Tong; Kwok-Hung Au; Roger Kai-Cheong Ngan; Foon-Yiu Cheung; Sin-Ming Chow; Yiu-Tung Fu; Joseph Siu-Kei Au; Stephen Chun-Key Law
Journal:  Head Neck Oncol       Date:  2012-05-18

10.  Risk-adapted partial larynx and/or carotid artery sparing modulated radiation therapy of glottic cancer.

Authors:  Stefan Janssen; Christoph Glanzmann; Gerhard Huber; Gabriela Studer
Journal:  Radiat Oncol       Date:  2014-06-13       Impact factor: 3.481
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.